Why the study?
Pulmonary embolism is accompanied by high morbidity and mortality, making risk stratification tools of key interest during patient hospitalizations.
Does Mansoor's Self-Report Tool for Cardiovascular Risk Assessment predict adverse in-hospital events in patients hospitalized with pulmonary embolism?
Does Mansoor's Self-Report Tool for Cardiovascular Risk Assessment predict adverse in-hospital events in patients hospitalized with pulmonary embolism?
Mansoor's Self-Report Tool for Cardiovascular Risk Assessment has poor prognostic performance for risk stratification in PE patients and cannot identify those who might benefit from systemic thrombolysis, though it moderately predicts bleeding risk.
Answers are grounded in this paper and cite their sources.
Poor performance precludes PE risk stratification or thrombolysis guidance; leaves open prospective validation of refined tools.
BACKGROUND: Pulmonary embolism (PE) is a life-threatening acute disease accompanied by high morbidity and mortality. Regarding hospitalizations of patients with PE, risk stratification of these patients is crucial. Thus, risk stratification tools like risk scores are of key interest. METHODS: The nationwide German inpatient sample of the years 2005-2018 was used for this present analysis. Hospitalized PE patients were stratified according to Mansoor's Self-Report Tool for Cardiovascular Risk Assessment class, and the performance of this score was evaluated to predict adverse in-hospital events. RESULTS: Overall, 1 174 196 hospitalizations of PE patients (53.5% females; 56.4% ≥70 years) were registered in Germany between 2005 and 2018. According to the Mansoor's self-report tool for cardiovascular risk assessment, 346 126 (29.5%) PE patients were classified as high risk. Higher Mansoor's Self-Report Tool for Cardiovascular Risk Assessment class was predictive for in-hospital death (OR 1.129 [95%CI 1.117-1.141], P < 0.001), shock (OR 1.117 [95%CI 1.095-1.140], P < 0.001), cardiopulmonary resuscitation (OR 1.109 [95%CI 1.092-1.126], P < 0.001), right ventricular dysfunction (OR 1.039 [95%CI 1.030-1.048], P < 0.001), intracerebral bleeding (OR 1.316 [95%CI 1.275-1.358], P < 0.001), and gastro-intestinal bleeding (OR 1.316 [95%CI 1.275-1.358], P < 0.001). Systemic thrombolysis was not associated with lower in-hospital mortality in high-risk class (OR 5.139 [95%CI 4.961-5.323], P < 0.001). CONCLUSIONS: Prognostic performance of the Mansoor's Self-Report Tool for Cardiovascular Risk Assessment for risk stratification of PE patients was poor and not able to identify those PE patients, who might benefit from systemic thrombolysis. However, the Mansoor's Self-Report Tool for Cardiovascular Risk Assessment was moderately helpful to identify PE patients at higher risk for bleeding events.
No takes yet. Share an insight, caveat, or question.
Keller et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: